Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, and have sudden weight loss. Moreover, they can have other mental and physical symptoms such as fatigue, memory loss, feeling of hopelessness, body aches, headaches, and thoughts of suicide.

Scope of the Report:

This report studies the Major Depressive Disorder market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Major Depressive Disorder market by product type and applications/end industries.

In terms of geography, North America dominates the global major depressive disorder market due to increased awareness about various depression conditions in the region. The U.S. represents the largest market for major depressive disorder in North America, followed by Canada. In Europe, Germany, France, the U.K., Italy, and Spain account for a major share of the major depressive disorder market. This market in Asia is expected to expand at a significant rate over the next five years. This is due to various companies setting up manufacturing facilities in the region. Moreover, increasing awareness about various depression episodes and rise in geriatric population are also driving the growth of the market in the region. India, China, and Japan are expected to be the fastest growing major depressive disorder markets in Asia.

The global Major Depressive Disorder market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Major Depressive Disorder.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Pfizer

Eli Lilly

H. Lundbeck

Otsuka Pharmaceutical

AstraZeneca

Alkermes

Takeda Pharmaceutical

Naurex

Euthymics Bioscience

E-therapeutics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Drugs Therapy

Biological Therapy

Meditation

Physiotherapy

Other

Market Segment by Applications, can be divided into

Under 25 Years Old

25-45 Years Old

Above 45 Years Old

Table of Contents

1 Major Depressive Disorder Market Overview

1.1 Product Overview and Scope of Major Depressive Disorder

1.2 Classification of Major Depressive Disorder by Types

1.2.1 Global Major Depressive Disorder Revenue Comparison by Types (2017-2023)

1.2.2 Global Major Depressive Disorder Revenue Market Share by Types in 2017

1.2.3 Drugs Therapy

1.2.4 Biological Therapy

1.2.5 Meditation

1.2.6 Physiotherapy

1.2.7 Other

1.3 Global Major Depressive Disorder Market by Application

1.3.1 Global Major Depressive Disorder Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Under 25 Years Old

1.3.3 25-45 Years Old

1.3.4 Above 45 Years Old

1.4 Global Major Depressive Disorder Market by Regions

1.4.1 Global Major Depressive Disorder Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Major Depressive Disorder Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Major Depressive Disorder Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Major Depressive Disorder Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Major Depressive Disorder Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Major Depressive Disorder Status and Prospect (2013-2023)

1.5 Global Market Size of Major Depressive Disorder (2013-2023)

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Major Depressive Disorder Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.2 Eli Lilly

2.2.1 Business Overview

2.2.2 Major Depressive Disorder Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Eli Lilly Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.3 H. Lundbeck

2.3.1 Business Overview

2.3.2 Major Depressive Disorder Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 H. Lundbeck Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.4 Otsuka Pharmaceutical

2.4.1 Business Overview

2.4.2 Major Depressive Disorder Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Otsuka Pharmaceutical Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.5 AstraZeneca

2.5.1 Business Overview

2.5.2 Major Depressive Disorder Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 AstraZeneca Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.6 Alkermes

2.6.1 Business Overview

2.6.2 Major Depressive Disorder Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Alkermes Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.7 Takeda Pharmaceutical

2.7.1 Business Overview

2.7.2 Major Depressive Disorder Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Takeda Pharmaceutical Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.8 Naurex

2.8.1 Business Overview

2.8.2 Major Depressive Disorder Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Naurex Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.9 Euthymics Bioscience

2.9.1 Business Overview

2.9.2 Major Depressive Disorder Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Euthymics Bioscience Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

2.10 E-therapeutics

2.10.1 Business Overview

2.10.2 Major Depressive Disorder Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 E-therapeutics Major Depressive Disorder Revenue, Gross Margin and Market Share (2016-2017)

3 Global Major Depressive Disorder Market Competition, by Players

3.1 Global Major Depressive Disorder Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Major Depressive Disorder Players Market Share

3.2.2 Top 10 Major Depressive Disorder Players Market Share

3.3 Market Competition Trend

4 Global Major Depressive Disorder Market Size by Regions

4.1 Global Major Depressive Disorder Revenue and Market Share by Regions

4.2 North America Major Depressive Disorder Revenue and Growth Rate (2013-2018)

4.3 Europe Major Depressive Disorder Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Major Depressive Disorder Revenue and Growth Rate (2013-2018)

4.5 South America Major Depressive Disorder Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Major Depressive Disorder Revenue and Growth Rate (2013-2018)

5 North America Major Depressive Disorder Revenue by Countries

5.1 North America Major Depressive Disorder Revenue by Countries (2013-2018)

5.2 USA Major Depressive Disorder Revenue and Growth Rate (2013-2018)

5.3 Canada Major Depressive Disorder Revenue and Growth Rate (2013-2018)

5.4 Mexico Major Depressive Disorder Revenue and Growth Rate (2013-2018)

6 Europe Major Depressive Disorder Revenue by Countries

6.1 Europe Major Depressive Disorder Revenue by Countries (2013-2018)

6.2 Germany Major Depressive Disorder Revenue and Growth Rate (2013-2018)

6.3 UK Major Depressive Disorder Revenue and Growth Rate (2013-2018)

6.4 France Major Depressive Disorder Revenue and Growth Rate (2013-2018)

6.5 Russia Major Depressive Disorder Revenue and Growth Rate (2013-2018)

6.6 Italy Major Depressive Disorder Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Major Depressive Disorder Revenue by Countries

7.1 Asia-Pacific Major Depressive Disorder Revenue by Countries (2013-2018)

7.2 China Major Depressive Disorder Revenue and Growth Rate (2013-2018)

7.3 Japan Major Depressive Disorder Revenue and Growth Rate (2013-2018)

7.4 Korea Major Depressive Disorder Revenue and Growth Rate (2013-2018)

7.5 India Major Depressive Disorder Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Major Depressive Disorder Revenue and Growth Rate (2013-2018)

8 South America Major Depressive Disorder Revenue by Countries

8.1 South America Major Depressive Disorder Revenue by Countries (2013-2018)

8.2 Brazil Major Depressive Disorder Revenue and Growth Rate (2013-2018)

8.3 Argentina Major Depressive Disorder Revenue and Growth Rate (2013-2018)

8.4 Colombia Major Depressive Disorder Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Major Depressive Disorder by Countries

9.1 Middle East and Africa Major Depressive Disorder Revenue by Countries (2013-2018)

9.2 Saudi Arabia Major Depressive Disorder Revenue and Growth Rate (2013-2018)

9.3 UAE Major Depressive Disorder Revenue and Growth Rate (2013-2018)

9.4 Egypt Major Depressive Disorder Revenue and Growth Rate (2013-2018)

9.5 Nigeria Major Depressive Disorder Revenue and Growth Rate (2013-2018)

9.6 South Africa Major Depressive Disorder Revenue and Growth Rate (2013-2018)

10 Global Major Depressive Disorder Market Segment by Type

10.1 Global Major Depressive Disorder Revenue and Market Share by Type (2013-2018)

10.2 Global Major Depressive Disorder Market Forecast by Type (2018-2023)

10.3 Drugs Therapy Revenue Growth Rate (2013-2023)

10.4 Biological Therapy Revenue Growth Rate (2013-2023)

10.5 Meditation Revenue Growth Rate (2013-2023)

10.6 Physiotherapy Revenue Growth Rate (2013-2023)

10.7 Other Revenue Growth Rate (2013-2023)

11 Global Major Depressive Disorder Market Segment by Application

11.1 Global Major Depressive Disorder Revenue Market Share by Application (2013-2018)

11.2 Major Depressive Disorder Market Forecast by Application (2018-2023)

11.3 Under 25 Years Old Revenue Growth (2013-2018)

11.4 25-45 Years Old Revenue Growth (2013-2018)

11.5 Above 45 Years Old Revenue Growth (2013-2018)

12 Global Major Depressive Disorder Market Size Forecast (2018-2023)

12.1 Global Major Depressive Disorder Market Size Forecast (2018-2023)

12.2 Global Major Depressive Disorder Market Forecast by Regions (2018-2023)

12.3 North America Major Depressive Disorder Revenue Market Forecast (2018-2023)

12.4 Europe Major Depressive Disorder Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Major Depressive Disorder Revenue Market Forecast (2018-2023)

12.6 South America Major Depressive Disorder Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Major Depressive Disorder Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Major Depressive Disorder Picture

Table Product Specifications of Major Depressive Disorder

Table Global Major Depressive Disorder and Revenue (Million USD) Market S